Obstetrics & Gynaecology Search

Obstetrics & Gynaecology

Obstetrics & Gynaecology

Home News Diseases Conferences Special Reports Multimedia

PELVIC INFLAMMATORY DISEASE

Pelvic inflammatory disease (PID) is the ascent of bacteria from the vagina or cervix resulting in infection of the reproductive organs eg uterus, fallopian tubes, ovaries. It may also be a complication of sexually transmitted infections.
The most common symptoms of PID are lower abdominal pain (crampy or dull) that usually starts a few days after the onset of the last menstrual period, dyspareunia, abnormal vaginal or cervical discharge, postcoital or irregular vaginal bleeding, dysuria, fever, nausea and vomiting, although some have minimal symptoms or silent pelvic inflammatory disease.

Pelvic%20inflammatory%20disease Patient Education

Patient Education

Patient needs to be informed about the nature of the infection & the importance of taking the full course of medication
Counsel patients on possible complications of sexually transmitted infection (STI)
Inform the patient of the possible short-term effects of PID (eg tubo-ovarian abscess) as well as long-term consequence (eg infertility, ectopic pregnancy, chronic pelvic pain)
- Incidence of long-term adverse effect of PID is directly related to the number of recurrences of PID

Patients should be advised to avoid unprotected sex until they & their partners have completed therapy & follow-up

Advise patients on how to lower their risk of acquiring sexually transmitted infections (STIs):

Tailor counseling to the patient’s specific risk factors
Abstinence, condom use
Careful selection of partners

Asia's trusted medical magazine for healthcare professionals. Get your MIMS JPOG - Malaysia digital copy today!

Abemaciclib + fulvestrant survival benefit extends to Asians with HR+, HER- ABC

Pearl Toh, 12 Jan 2021

Adding the CDK4/6 inhibitor abemaciclib to an endocrine therapy of fulvestrant extends overall survival (OS) compared with fulvestrant alone in East Asian patients with hormone receptor-positive (HR+), HER2-negative advanced breast cancer (ABC) who have progressed on prior endocrine therapy, consistent with results from the overall population, updated analysis of the global, phase III MONARCH 2 study has shown.

Acute diarrhoea is the second leading cause of death in children aged younger than 5 years, accounting for approximately 1.9 million deaths worldwide each year; however, diarrhoea is a preventable and treatable condition. In Malaysia, acute gastroenteritis accounts for about 1.3% of all deaths in children aged younger than 5 years annually. Diarrhoea is defined as the passage of three or more loose or watery stools within 24 hours, and it may be clinically categorised as either acute watery diarrhoea (AWD), acute bloody diarrhoea, persistent diarrhoea or diarrhoea with severe malnutrition.

01 Sep 2020

Acute diarrhoea is the second leading cause of deathin children aged younger than 5 years, accounting forapproximately 1.9 million deaths worldwide each year;however, diarrhoea is a preventable and treatable condition.In Malaysia, acute gastroenteritis accounts for about 1.3%of all deaths in children aged younger than 5 years annually.Diarrhoea is defined as the passage of three or more looseor watery stools within 24 hours, and it may be clinicallycategorised as either acute watery diarrhoea (AWD), acutebloody diarrhoea, persistent diarrhoea or diarrhoea withsevere malnutrition.